Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 7537
  • Home
  • Print this page
  • Email this page
Year : 2016  |  Volume : 64  |  Issue : 1  |  Page : 14-25

Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines

1 L. V. Prasad Eye Institute, Hyderabad, Telangana, India
2 Delhi Retina Center, New Delhi, India
3 Giridhar Eye Institute, Kochi, Kerala, India
4 RP Centre for Ophthalmic Sciences, New Delhi, India
5 Sankara Nethralaya, Chennai, Tamil Nadu, India
6 Retina Foundation, Ahmedabad, Gujarat, India
7 Aditya Jyot Eye Hospital, Mumbai, Maharashtra, India
8 Aravind Eye Care System, Madurai, Tamil Nadu, India
9 Centre for Sight, New Delhi, India

Correspondence Address:
Taraprasad Das
L. V. Prasad Eye Institute, Banjara Hills, Hyderabad - 500 034, Telangana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0301-4738.178142

Rights and Permissions

The purpose of the study was to review the current evidence and design a diabetic macular edema (DME) management guideline specific for India. The published DME guidelines from different organizations and publications were weighed against the practice trends in India. This included the recently approved drugs. DME management consisted of control of diabetes and other associated systemic conditions, such as hypertension and hyperlipidemia, and specific therapy to reduce macular edema. Quantification of macular edema is precisely made with the optical coherence tomography and treatment options include retinal laser, intravitreal anti-vascular endothelial growth factors (VEGF), and implantable dexamethasone. Specific use of these modalities depends on the presenting vision and extent of macular involvement. Invariable eyes with center-involving macular edema benefit from intravitreal anti-VEGF or dexamethasone implant therapy, and eyes with macular edema not involving the macula center benefit from retinal laser. The results are illustrated with adequate case studies and frequently asked questions. This guideline prepared on the current published evidence is meant as a guideline for the treating physicians.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1511    
    Comments [Add]    

Recommend this journal